-
Something wrong with this record ?
Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment
R. Hobzova, J. Sirc, K. Shrestha, B. Mudrova, Z. Bosakova, M. Slouf, M. Munzarova, J. Hrabeta, T. Feglarova, AI. Cocarta
Status not-indexed Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2010
Free Medical Journals
from 2010
PubMed Central
from 2009
Europe PubMed Central
from 2009
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
- Publication type
- Journal Article MeSH
Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23009839
- 003
- CZ-PrNML
- 005
- 20230721095435.0
- 007
- ta
- 008
- 230707s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/pharmaceutics15051398 $2 doi
- 035 __
- $a (PubMed)37242640
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hobzova, Radka $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic $1 https://orcid.org/0000000268688046
- 245 10
- $a Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment / $c R. Hobzova, J. Sirc, K. Shrestha, B. Mudrova, Z. Bosakova, M. Slouf, M. Munzarova, J. Hrabeta, T. Feglarova, AI. Cocarta
- 520 9_
- $a Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sirc, Jakub $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
- 700 1_
- $a Shrestha, Kusum $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
- 700 1_
- $a Mudrova, Barbora $u Department of Analytical Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic
- 700 1_
- $a Bosakova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, 128 43 Prague, Czech Republic $1 https://orcid.org/0000000284835739 $7 jo2005273839
- 700 1_
- $a Slouf, Miroslav $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic $1 https://orcid.org/000000031528802X $7 xx0107048
- 700 1_
- $a Munzarova, Marcela $u Nanomedical Co., Ltd., 463 12 Liberec, Czech Republic
- 700 1_
- $a Hrabeta, Jan $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic
- 700 1_
- $a Feglarova, Tereza $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic
- 700 1_
- $a Cocarta, Ana-Irina $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, 162 06 Prague, Czech Republic
- 773 0_
- $w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 15, č. 5 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37242640 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230721095428 $b ABA008
- 999 __
- $a ok $b bmc $g 1958525 $s 1196103
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 15 $c 5 $e 20230503 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
- LZP __
- $a Pubmed-20230707